SCHEMBL660915

SCHEMBL660915

COC(=O)C(C(=O)OC)C(CC(=O)c1ccc(O)cc1)c1ccc(Cl)cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.60
POLB P06746 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 1/20 0.47
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
KMT2A Q03164 4/20 0.43
MAPK1 P28482 1/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
ESRRB O95718 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659208 0.88 L3MBTL1 (0.59) L3MBTL1POLBCYP2C9CYP2C19KMT2A
SCHEMBL657922 0.87 CYP2C9 (0.61) L3MBTL1POLBNPC1RAB9ACYP2C9
SCHEMBL658474 0.85 PDPK1 (0.56) L3MBTL1POLBALDH1A1MAPT
SCHEMBL659733 0.84 L3MBTL1 (0.54) L3MBTL1POLBNPC1RAB9ACYP2C9
SCHEMBL657707 0.83 PDPK1 (0.56) L3MBTL1POLBNPC1RAB9ACYP2C9
SCHEMBL657267 0.82 L3MBTL1 (0.56) L3MBTL1POLBNPC1RAB9ACYP2C9
SCHEMBL23149235 0.81 L3MBTL1 (0.52) L3MBTL1POLBRAB9ACYP2C9CYP2C19
SCHEMBL7109702 0.77 KMT2A (0.66) L3MBTL1POLBNPC1RAB9AKMT2A
SCHEMBL13386471 0.77 POLB (0.57) L3MBTL1POLBNPC1RAB9ACYP2C9
SCHEMBL10448370 0.77 KMT2A (0.66) L3MBTL1POLBNPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB L3MBTL1 3302/4885POLB 4008/4885NPC1 2687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.